VTRO (Vitro Biopharma) Total Assets: $8.57 Mil (As of Oct. 2022)

What is Vitro Biopharma Total Assets?

Vitro Biopharma VTRO Total Assets is $8.57 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's Total Assets for the quarter that ended in Oct. 2022 was $8.57 Mil.

Warning Sign:

If a company builds assets at 188% a year, faster than its revenue growth rate of 132.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Vitro Biopharma's average Total Assets Growth Rate was 4.40% per year. During the past 3 years, the average Total Assets Growth Rate was 313.20% per year. During the past 5 years, the average Total Assets Growth Rate was 188.00% per year. During the past 10 years, the average Total Assets Growth Rate was 47.60% per year.

During the past 13 years, Vitro Biopharma's highest 3-Year average Total Assets Growth Rate was 317.60%. The lowest was -32.90%. And the median was 3.20%.

Total Assets is connected with ROA %. Vitro Biopharma's annualized ROA % for the quarter that ended in Oct. 2022 was -278.54%. Total Assets is also linked to Revenue through Asset Turnover. Vitro Biopharma's Asset Turnover for the quarter that ended in Oct. 2022 was 0.33.

Vitro Biopharma (AMEX:VTRO) Total Assets Explanation

Total Assets is connected with ROA %.

Vitro Biopharma's annualized ROA % for the quarter that ended in Oct. 2022 is

ROA %	=	Net Income (Q: Oct. 2022 )	/	( (Total Assets (Q: Oct. 2021 )	+	Total Assets (Q: Oct. 2022 ))	/ count )
	=	-27.44	/	( (11.129	+	8.574)	/ 2 )
	=	-27.44	/	9.8515
	=	-278.54 %

Note: The Net Income data used here is four times the quarterly (Oct. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Vitro Biopharma's Asset Turnover for the quarter that ended in Oct. 2022 is

	Asset Turnover
=	Revenue (Q: Oct. 2022 )	/	( (Total Assets (Q: Oct. 2021 )	+	Total Assets (Q: Oct. 2022 ))	/ count )
=	3.293	/	( (11.129	+	8.574)	/ 2 )
=	3.293	/	9.8515
=	0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Vitro Biopharma Total Assets Related Terms

Vitro Biopharma Total Assets Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Total Assets can be seen below:

Vitro Biopharma Total Assets Chart

Vitro Biopharma Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Oct17

Oct21

Oct22

Total Assets

Get a 7-Day Free Trial

0.11

0.12

0.26

11.13

8.57

Vitro Biopharma Quarterly Data
	Oct00	Oct01	Oct02	Oct03	Oct04	Oct05	Oct06	Oct07	Oct08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15	Oct17	Oct21	Oct22
Total Assets	Get a 7-Day Free Trial														0.11	0.12	0.26	11.13	8.57

Vitro Biopharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Vitro Biopharma's Total Assets for the fiscal year that ended in Oct. 2022 is calculated as

Total Assets	=	Total Equity (A: Oct. 2022 )	+	Total Liabilities (A: Oct. 2022 )
	=	2.836	+	5.738
	=	8.57

Vitro Biopharma's Total Assets for the quarter that ended in Oct. 2022 is calculated as

Total Assets	=	Total Equity (Q: Oct. 2022 )	+	Total Liabilities (Q: Oct. 2022 )
	=	2.836	+	5.738
	=	8.57

Frequently Asked Questions Learn more about Total Assets →

What does a Total Assets of $8.57 Mil mean?

Vitro Biopharma (VTRO) has a Total Assets of $8.57 Mil as of Oct. 2022. The total amount of assets as recorded on a company's balance sheet. View historical data on Vitro Biopharma and its competitors.

Is Vitro Biopharma's Total Assets too high?

Vitro Biopharma's current Total Assets is $8.57 Mil.

How does Vitro Biopharma's Total Assets compare to ?

Vitro Biopharma's Total Assets of $8.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Assets for a Biotechnology company?

A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Assets mean?

A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current Total Assets is $8.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vitro Biopharma stock overvalued right now?

Vitro Biopharma (VTRO) has a current Total Assets of $8.57 Mil. The current Total Assets is $8.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Assets calculated?

Total Assets is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Total Assets is $8.57 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Industry Healthcare Biotechnology

Comparable Companies

Address 4621 Technology Drive, Golden, CO, USA, 80403

Website http://www.vitrobiopharma.com

Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.